Suh et al applied LVs to deliver ABE and a sgRNA targeting the Rpe65 gene mutation for Leber’s congenital amaurosis, with a gene correction efficiency of 29% and improved retinal and visual function.162. This evidence concerns the gene RPE65 and Leber congenital amaurosis.